Literature DB >> 12526923

Fc epsilon RI and CD22 mRNA are expressed in early B-lineage and myeloid leukemia cell lines.

Ken Toba1, Haruo Hanawa, Minori Sakaue, Kaori Yoshida, Hiromi Itoh, Junjiro Tsuchiyama, Soichi Maruyama, Miwako Narita, Masuhiro Takahashi, Kenichi Watanabe, Yoshifusa Aizawa.   

Abstract

CD22, one of the important markers for diagnosing B-lineage acute leukemia, was expressed in mature basophil granulocytes. We then investigated the expression of CD22 and other B cell- and basophil-related molecules in 25 human acute leukemia cell lines to find the phenotype of the virtual common progenitor of B and myeloid lineage. Surface and cytoplasmic expressions of antigens were analyzed using a flow cytometer and an essential antibody panel used for diagnosing acute leukemia as well as cytokine receptors and basophil-related enzymes. Messenger RNA expression of Fc epsilon R1 and CD22 was also analyzed. Peroxidase-positive and -negative myeloid leukemias showed eosinophil- and basophil-type expression of enzymes, respectively. Early myeloid and B-lineage cells expressed basically similar combinations of cytokine receptors and various combinations of mRNA listed above, while T-lineage cells did not. The virtual common progenitor of B and myeloid lineage cells may be defined as immature cells simultaneously expressing B and basophil phenotypes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12526923     DOI: 10.1016/s0145-2126(02)00086-3

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  2 in total

1.  Differential Evolution between Monotocous and Polytocous Species.

Authors:  Hyeonju Ahn; Kyu-Won Kim; Hyeon Jeong Kim; Seoae Cho; Heebal Kim
Journal:  Asian-Australas J Anim Sci       Date:  2014-04       Impact factor: 2.509

2.  In silico analyses reveal common cellular pathways affected by loss of heterozygosity (LOH) events in the lymphomagenesis of Non-Hodgkin's lymphoma (NHL).

Authors:  Carlos Aya-Bonilla; Emily Camilleri; Larisa M Haupt; Rod Lea; Maher K Gandhi; Lyn R Griffiths
Journal:  BMC Genomics       Date:  2014-05-21       Impact factor: 3.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.